1. 5PSQ-014 Impact of histamine-2 antagonist shortage on the incidence of hypersensitivity reactions to paclitaxel – towards crisis management and a premedication reconsideration in France (PACLIREACT Study). Issue 1 (23rd March 2023) Authors: Strobbe, G; Gaboriau, L; Abele, M; Villain, A; Aelbrecht-Meurisse, C; Carnot, A; Le Deley, MC; Léguillette, C; Sakji, I; Feutry, F; Marliot, G Journal: European journal of hospital pharmacy Issue: Volume 30:Issue 1(2023)supplement 1 Page Start: A115 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P11.52.A Peripheral neuropathies after BRAF and/or MEK inhibitors treatment: a pharmacovigilance study. (5th September 2022) Authors: Picca, A; Birzu, C; Berzero, G; Sanchez-Pena, P; Gaboriau, L; Vidil, F; Lenglet, T; Tafani, C; Ricard, D; Psimaras, D; Bihan, K Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 2 Page Start: ii69 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. SAT0144 Tumor necrosis factor-alpha inhibitors and psychiatric side effects: results from the french pharmacovigilance database. (15th June 2017) Authors: Yelnik, CM; Gaboriau, L; Petitpain, N; Théophile, H; Scalbert, C; Delaporte, E; Gautier, S; Lambert, M Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 823 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗